BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16042792)

  • 1. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine.
    Akan I; Akan S; Akca H; Savas B; Ozben T
    Cancer Cell Int; 2005 Jul; 5(1):22. PubMed ID: 16042792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
    Akan I; Akan S; Akca H; Savas B; Ozben T
    Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.
    Gana CC; Hanssen KM; Yu DMT; Flemming CL; Wheatley MS; Conseil G; Cole SPC; Norris MD; Haber M; Fletcher JI
    Biochem Pharmacol; 2019 Oct; 168():237-248. PubMed ID: 31302132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
    Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
    Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy.
    Rappa G; Gamcsik MP; Mitina RL; Baum C; Fodstad O; Lorico A
    Eur J Cancer; 2003 Jan; 39(1):120-8. PubMed ID: 12504668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
    Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
    Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific effects of fenthion on glutathione metabolism modulated by NAC and BSO in Oreochromis niloticus.
    Sevgiler Y; Uner N
    Drug Chem Toxicol; 2010 Oct; 33(4):348-56. PubMed ID: 20550428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.
    Sharp SY; Smith V; Hobbs S; Kelland LR
    Br J Cancer; 1998 Jul; 78(2):175-80. PubMed ID: 9683290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine.
    van Brussel JP; Oomen MA; Vossebeld PJ; Wiemer EA; Sonneveld P; Mickisch GH
    BJU Int; 2004 Jun; 93(9):1333-8. PubMed ID: 15180633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
    Versantvoort CH; Broxterman HJ; Bagrij T; Scheper RJ; Twentyman PR
    Br J Cancer; 1995 Jul; 72(1):82-9. PubMed ID: 7599070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein, MRP1.
    Bagrij T; Klokouzas A; Hladky SB; Barrand MA
    Biochem Pharmacol; 2001 Jul; 62(2):199-206. PubMed ID: 11389878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.
    Renes J; de Vries EG; Nienhuis EF; Jansen PL; Müller M
    Br J Pharmacol; 1999 Feb; 126(3):681-8. PubMed ID: 10188979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM2 channel protective properties of N-acetylcysteine on cytosolic glutathione depletion dependent oxidative stress and Ca2+ influx in rat dorsal root ganglion.
    Özgül C; Nazıroğlu M
    Physiol Behav; 2012 May; 106(2):122-8. PubMed ID: 22300897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1.
    Watts RN; Hawkins C; Ponka P; Richardson DR
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7670-5. PubMed ID: 16679408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glutathione redox cycle and catalase in defense against oxidative stress induced by endosulfan in adrenocortical cells of rainbow trout (Oncorhynchus mykiss).
    Dorval J; Hontela A
    Toxicol Appl Pharmacol; 2003 Oct; 192(2):191-200. PubMed ID: 14550752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.
    Rocha Gda G; Oliveira RR; Kaplan MA; Gattass CR
    Eur J Pharmacol; 2014 Oct; 741():140-9. PubMed ID: 25111243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
    Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
    Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Fruehauf JP; Zonis S; al-Bassam M; Kyshtoobayeva A; Dasgupta C; Milovanovic T; Parker RJ; Buzaid AC
    Chem Biol Interact; 1998 Apr; 111-112():277-305. PubMed ID: 9679561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.